Category: M
Royal Mail Tracked 24 (Signed For)
Royal Mail Special Delivery Guaranteed by 1pm
Category | POM-V |
Temperature | Ambient |
MA/VM/EU No: | 00879/4040 |
Species |
|
VMD Link | https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_172749.PDF |
NOAH Link | |
Dosage | Amounts to be administered and administration route Minimum recommended dose rate: 0.5 mg of milbemycin oxime and 5 mg of praziquantel per kg are given once orally. The product should be administered with or after some food. Depending on the bodyweight of the dog, the practical dosing is as follows: Weight Tablets 5 – 25 kg 1 tablet >25 – 50 kg 2 tablets >50 – 75 kg 3 tablets In cases when heartworm disease prevention is used and at the same time treatment against tapeworm is required, MILBEMAX can replace the monovalent product for the prevention of heartworm disease. For treatment of Angiostrongylus vasorum infections , milbemycin oxime should be given four times at weekly intervals. It is recommended, where concomitant treatment against cestodes is indicated, to treat once with MILBEMAX and continue with the monovalent product containing milbemycin oxime alone, for the remaining three weekly treatments. In endemic areas administration of the product every four weeks will prevent angiostrongylosis by reducing immature adult (L5) and adult parasite burden, where concomitant treatment against cestodes is indicated. For the treatment of Thelazia callipaeda, milbemycin oxime should be given in 2 treatments, seven days apart. Where concomitant treatment against cestodes is indicated, MILBEMAX can replace the monovalent product containing milbemycin oxime alone. For guidance on dosing intervals reference should be made to ESCCAP Guidelines which currently advise that, administration of the product every four weeks is effective against D. immitis third stage larvae (L3) and L4 which have developed within the previous 30 days and thus prevents disease caused by the adult worms. Administration of the product should begin within one month of first exposure with the last dose given within one month after the end of exposure. Before starting any prophylactic treatment, adult D. immitis (or D. repens) infections must be ruled out by testing for circulating antigen or microfilariae. Heartworm-infected animals should first be treated for adult worms; prophylactic treatment can begin around 4 weeks later. Overdose (symptoms, emergency procedures, antidotes), if necessary No other signs than those observed at the recommended dose have been observed (see section Adverse Reactions). |
Withdrawals |